IL166533A0 - 2-substituted bicyclic benzoheterocylic compounds and their use as sodium channel blockers - Google Patents

2-substituted bicyclic benzoheterocylic compounds and their use as sodium channel blockers

Info

Publication number
IL166533A0
IL166533A0 IL16653303A IL16653303A IL166533A0 IL 166533 A0 IL166533 A0 IL 166533A0 IL 16653303 A IL16653303 A IL 16653303A IL 16653303 A IL16653303 A IL 16653303A IL 166533 A0 IL166533 A0 IL 166533A0
Authority
IL
Israel
Prior art keywords
benzoheterocylic
compounds
sodium channel
channel blockers
substituted bicyclic
Prior art date
Application number
IL16653303A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL166533A0 publication Critical patent/IL166533A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/081,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IL16653303A 2002-08-01 2003-07-30 2-substituted bicyclic benzoheterocylic compounds and their use as sodium channel blockers IL166533A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39970202P 2002-08-01 2002-08-01
PCT/US2003/023791 WO2004013111A1 (en) 2002-08-01 2003-07-30 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers

Publications (1)

Publication Number Publication Date
IL166533A0 true IL166533A0 (en) 2006-01-15

Family

ID=31495754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16653303A IL166533A0 (en) 2002-08-01 2003-07-30 2-substituted bicyclic benzoheterocylic compounds and their use as sodium channel blockers

Country Status (11)

Country Link
US (1) US20040152696A1 (de)
EP (1) EP1534690A1 (de)
JP (1) JP2006500343A (de)
KR (1) KR20050026094A (de)
CN (1) CN1678592A (de)
AU (1) AU2003257015A1 (de)
BR (1) BR0313369A (de)
CA (1) CA2493737A1 (de)
IL (1) IL166533A0 (de)
MX (1) MXPA05001288A (de)
WO (1) WO2004013111A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR065081A1 (es) * 2007-01-29 2009-05-13 Xenon Pharmaceuticals Inc Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
AU2011303597A1 (en) 2010-09-17 2013-04-11 Purdue Pharma L.P. Pyridine compounds and the uses thereof
KR20130095772A (ko) 2010-10-05 2013-08-28 퍼듀 퍼머 엘피 나트륨 채널 차단제로서 퀴나졸린 화합물
EP2655330B1 (de) 2010-12-22 2016-02-10 Purdue Pharma LP Substutuierte pyridine als kaliumkanalblocker
UY34171A (es) * 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
EP3255041A1 (de) 2011-09-02 2017-12-13 Purdue Pharma L.P. Pyrimidine als natriumkanalblocker
WO2013064883A1 (en) 2011-10-31 2013-05-10 Purdue Pharma L.P. Heteroaryl compounds as sodium channel blockers
WO2013064884A1 (en) 2011-10-31 2013-05-10 Purdue Pharma L.P. Quaternized amines as sodium channel blockers
US9133131B2 (en) 2011-11-15 2015-09-15 Purdue Pharma L.P. Pyrimidine diol amides as sodium channel blockers
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
EP2925719A4 (de) 2012-11-28 2016-07-13 Yansong Lu Neuartige synthetische antioxidantien und deren verwendungen
EP2935257B1 (de) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclische sulfonamide als natriumkanalblocker
US9120786B2 (en) 2013-03-04 2015-09-01 Purdue Pharma, L.P. Triazine carboxamides as sodium channel blockers
WO2014135955A1 (en) 2013-03-04 2014-09-12 Purdue Pharma L.P. Pyrimidine carboxamides as sodium channel blockers
CA2939549C (en) 2013-03-15 2020-08-18 Purdue Pharma L.P. Carboxamide derivatives and use thereof
CN105612152A (zh) 2013-08-26 2016-05-25 普渡制药公司 氮杂螺[4.5]癸烷衍生物及其用途
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
US9745287B2 (en) 2013-12-20 2017-08-29 Purdue Pharma L.P. Pyrimidines and use thereof
US9695144B2 (en) 2013-12-23 2017-07-04 Purdue Pharma L.P. Dibenzazepine derivatives and use thereof
JP6337124B2 (ja) 2013-12-23 2018-06-06 パーデュー、ファーマ、リミテッド、パートナーシップ インダゾール及びその使用
EP3089978B1 (de) 2013-12-30 2018-08-29 Purdue Pharma L.P. Pyridonsulfonmorphinan-analoga als opioidrezeptorliganden
JP6526023B2 (ja) 2014-01-24 2019-06-05 パーデュー、ファーマ、リミテッド、パートナーシップ ピリジン類及びピリミジン類並びにその使用
AU2015217185B2 (en) 2014-02-12 2018-04-05 Purdue Pharma L.P. Isoquinoline derivatives and use thereof
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
CA2948144A1 (en) 2014-05-06 2015-11-12 Purdue Pharma L.P. Benzomorphan analogs and use thereof
WO2015192039A1 (en) 2014-06-13 2015-12-17 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
CN117756744B (zh) * 2023-12-14 2025-11-25 常州大学 一种2-取代的-2,3-二氢-4h-苯并噻嗪-4-酮的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322766A (en) * 1964-11-13 1967-05-30 Shulton Inc 3-beta-(4-pyridyl) ethyl-2, 3-dihydro-4(1h)-quinazolinones
US3459748A (en) * 1967-04-28 1969-08-05 Squibb & Sons Inc Hydroxyalkylene-substituted benzoxazines and benzothiazines
WO2001023365A1 (en) * 1999-09-28 2001-04-05 Merck Patent Gmbh Quinazolinones
AR029489A1 (es) * 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
AU4589701A (en) * 2000-03-24 2001-10-08 Cocensys Inc Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
AU4961001A (en) * 2000-03-31 2001-10-15 Cocensys Inc Aminopyridines and their use as anticonvulsants and sodium channel blockers
IL159765A0 (en) * 2001-07-16 2004-06-20 Euro Celtique Sa Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
AR037233A1 (es) * 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
MXPA04008901A (es) * 2002-03-13 2004-11-26 Euro Celtique Sa Pirimidinas arilo sustituidas y el uso de las mismas.

Also Published As

Publication number Publication date
CA2493737A1 (en) 2004-02-12
US20040152696A1 (en) 2004-08-05
MXPA05001288A (es) 2005-09-08
AU2003257015A1 (en) 2004-02-23
EP1534690A1 (de) 2005-06-01
BR0313369A (pt) 2005-06-21
CN1678592A (zh) 2005-10-05
JP2006500343A (ja) 2006-01-05
WO2004013111A1 (en) 2004-02-12
KR20050026094A (ko) 2005-03-14

Similar Documents

Publication Publication Date Title
IL166533A0 (en) 2-substituted bicyclic benzoheterocylic compounds and their use as sodium channel blockers
IL166366A0 (en) Aryl substituted benzimidazoles and their use as sodium channel blockers
EP1542686A4 (de) Aryl-substituierte hydantoin-verbindungen und ihre verwendung als natriumkanalblocker
IL166364A0 (en) Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
TW547058U (en) Sectional curtain
ZA200407609B (en) Use of vitamin d compounds
GB0226727D0 (en) Intrabodies
ZA200409686B (en) Bicyclic 6-aklylidene-penems as ?-lactamases inhibitors
GB2411172B (en) Dimetalhydroxy malates
IL164698A0 (en) Attenuation of metapneumovirus
IL172848A0 (en) 2-substituted pyrimidines
PL376897A1 (pl) Podstawione 6-(2-chlorowcofenylo) triazolopirymidyny
IL165290A0 (en) Rescue sleeve for buildings
DE50305424D1 (en) Photodiode
AU153329S (en) Light fitting
IL172845A0 (en) 2-substituted pyrimidines
GB0212188D0 (en) Glazing
GB0225038D0 (en) Shade
TW560311U (en) Dual-purposed eyesight examiner
SI1485359T1 (sl) Blokatorji natrijevega kanala
GB2383836B (en) Light fitting
GB0224624D0 (en) Light fitting
TW582257U (en) Safe washbasin
GB0218043D0 (en) New use of diaza-anthracene compounds
GB0217750D0 (en) New use of diaza-anthracene compounds